tiprankstipranks
Trending News
More News >
Jupiter Neurosciences, Inc. (JUNS)
NASDAQ:JUNS
US Market

Compare Jupiter Neurosciences, Inc. (JUNS) vs. Competitors

Compare
189 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Jupiter Neurosciences, Inc.
$0.86
$27.89M
-3.79
-84.04%
1 Buy
0 Hold
0 Sell
Moderate Buy
Relmada Therapeutics
$4.11
$281.60M
-2.11
859.60%
2 Buy
0 Hold
0 Sell
Moderate Buy
Gain Therapeutics
$1.88
$84.62M
-2.94
-12.15%
4 Buy
0 Hold
0 Sell
Strong Buy
MiNK Therapeutics
$11.83
$55.02M
-3.90
36.01%
1 Buy
0 Hold
0 Sell
Moderate Buy
Adlai Nortye Ltd. Sponsored ADR
$1.68
$59.41M
-17.24%
0 Buy
1 Hold
0 Sell
Hold
OS Therapies Incorporated
$1.44
$54.58M
-1.79
-66.51%
2 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
JUNS
Jupiter Neurosciences, Inc.
0.86
-3.54
-80.41%
RLMD
Relmada Therapeutics
3.80
3.43
927.03%
GANX
Gain Therapeutics
1.88
-0.40
-17.54%
INKT
MiNK Therapeutics
11.83
3.03
34.43%
ANL
Adlai Nortye Ltd. Sponsored ADR
1.68
-0.37
-18.05%
OSTX
OS Therapies Incorporated
1.46
-1.49
-50.51%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts